BioNTech SE ADR buy Gilbert
Start price
23.09.21
/
50%
€291.70
Target price
23.09.25
-
Performance (%)
-67.72%
End price
12.01.24
€94.16
Summary
This prediction ended on 12.01.24 with a price of €94.16. Massive losses of -67.72% were the result for the BUY prediction by Gilbert. Gilbert has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
BioNTech SE ADR | 7.896% | 7.896% | 243.124% |
iShares Core DAX® | 2.112% | -0.367% | 13.466% |
iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% |
iShares Nikkei 225® | -1.555% | -7.320% | 18.451% |
iShares S&P 500 | -0.472% | -2.078% | 27.488% |
According to Gilbert what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
Growths faster than the competition
Could be worthwhile Investment >10% per year
Cons
High risks in the balance sheet
Comments by Gilbert for this prediction
In the thread Biontech SE diskutieren
Buy BioNTech SE ADR
Stopped prediction by Gilbert for BioNTech SE ADR
BioNTech SE ADR
Start price
Target price
Perf. (%)
€378.60
10.08.21
10.08.21
-
10.08.24
10.08.24
2.06%
10.08.21
10.08.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€184.50
09.07.21
09.07.21
-
09.07.22
09.07.22
-0.11%
09.07.21
09.07.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€162.50
10.05.21
10.05.21
-
10.05.26
10.05.26
1.60%
27.05.21
27.05.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€125.05
17.04.21
17.04.21
-
17.04.23
17.04.23
5.28%
06.05.21
06.05.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€99.38
08.02.21
08.02.21
-
08.02.22
08.02.22
26.58%
16.04.21
16.04.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€96.99
08.02.21
08.02.21
-
08.02.22
08.02.22
2.46%
08.02.21
08.02.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€84.76
13.01.21
13.01.21
€103.00
14.43%
08.02.21
08.02.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet